SellYourAIData
Get a free valuation Contact

AI Data Deal TrackerDeal brief

×

Segmed, NVIDIA and RadImageNet team up to license synthetic medical imaging data

Segmed partnered with NVIDIA and RadImageNet to produce and commercialize synthetic medical imaging data for research and development. Researchers and companies can license the data through Segmed's Insight platform, which also holds more than 60 million de-identified real-world imaging records.

APRIL 18, 2023 Segmed, NVIDIA and RadImageNet announced a partnership to produce and commercialize synthetic medical imaging data for research and development, AuntMinnie reported.1

Terms of the deal

Segmed will offer the synthetic data on its Insight medical data curation platform, which will also keep its existing real-world data.1 Generative models trained on CT, MRI, ultrasound and endoscopic surgery data can produce over 160 pathologic classifications and synthetic segmentations.1 Medical researchers and companies can license the data.1

Segmed's platform includes more than 60 million de-identified real-world imaging records. The article gives no count for the synthetic data, and no price or customer names.1

What it means for data sellers

The announcement is an example of a data broker adding a synthetic product line next to licensed real-world records. For hospitals and imaging centers it shows one route by which de-identified imaging data reaches AI developers: through an intermediary that curates and re-packages it. Terms for the original data suppliers were not reported.

This entry is a news summary. SellYourAIData was not involved in the deal.

How the deal came together

  1. Three-way partnership. Segmed, NVIDIA and RadImageNet announced a joint effort to produce and commercialize synthetic medical imaging data.
  2. Generative models make the data. Models trained on CT, MRI, ultrasound and endoscopic surgery data can produce more than 160 pathologic classifications and synthetic segmentations.
  3. Sold through a platform. Segmed will offer the synthetic data on its Insight medical data curation platform, alongside its existing real-world data.
  4. Licensing to buyers. Medical researchers and companies can license the data.

Takeaways for companies with data

  • Synthetic data lets a seller package a licensable product that is one step removed from patient records.
  • A platform that already holds de-identified real-world records, here more than 60 million, is the base for new data products.
  • No prices or customers were disclosed, so the announcement shows a product launch rather than a measured market price.

Sources

Every numbered reference above points to an entry here. Figures come from these pages as of the date shown at the top of the article. Where a source reports a number it got from unnamed people, the text says so.

  1. Segmed teams with Nvidia and RadImageNet (AuntMinnie, April 2023)

###

About the AI Data Deal Tracker

SellYourAIData tracks publicly reported sales and licenses of data to AI companies, with the price, terms and sources for each. Entries are checked against public reporting and updated as deals change. SellYourAIData was not involved in this deal. To ask what your company's data could sell for, get a free valuation. To report a deal, contact us.